Latest News & Updates
Breaking News
11 hours ago
Simantini Singh Deo
Other trending news you may like to read
Everest Medicines Signs Exclusive Asia-Pacific Licensing Deal for Bejescin in Nephrology and Autoimmune Indications
Everest Medicines secures exclusive Asia-Pacific rights to Bejescin, expanding its nephrology and autoimmune portfolio across a multi-regulator region.
Simantini Singh Deo
Lupin Manufacturing Solutions Appoints Eduardo Jule as Chief Commercial Officer to Drive Global CDMO Expansion
Lupin Manufacturing Solutions names Eduardo Jule CCO to accelerate CDMO and API growth in regulated Western markets.
Simantini Singh Deo
LENZ Therapeutics Signs Greater China Rights Deal with Everest Medicines for VIZZ Ophthalmic Drug
LENZ Therapeutics transfers VIZZ Greater China rights to Everest Medicines, with NMPA approval targeted Q1 2027 and $85M in milestones retained.
Simantini Singh Deo
Boehringer Ingelheim Achieves Phase III Endpoints for Survodutide Across Obesity and MASLD Populations
Boehringer Ingelheim's survodutide met Phase III endpoints in obesity and MASLD, posting 34% visceral and 63% liver fat reductions.
Simantini Singh Deo
